【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market overview
03.2 Product offerings
04.Market Research Methodology
04.1 Market research process
04.2 Research methodology
05.Introduction
06.Disease Overview: Crohn’s Disease
06.1 Understanding the disease
06.2 Etiology
06.2.1 Autoimmune reaction
06.2.2 Genes
06.2.3 Environment
06.3 Stages of Crohn’s disease
06.4 Epidemiology
06.4.1 Worldwide prevalence of Crohn’s disease
06.4.2 US
06.4.3 UK
06.5 Symptoms
06.5.1 Diarrhea
06.5.2 Fever and fatigue
06.5.3 Abdominal pain and cramping
06.5.4 Perianal disease and blood in stool
06.5.5 Reduced appetite and weight loss
06.6 Diagnosis and testing
06.6.1 Early tests and exams
06.6.2 Endoscopy and biopsy
06.6.3 Chromoendoscopy
06.6.4 Small intestinal imaging
06.7 Treatment
06.7.1 Medication
06.7.2 Diet and nutrition
06.7.3 Surgery
07.Disease Overview: Ulcerative Colitis
07.1 Understanding the disease
07.2 Etiology
07.2.1 Autoimmune reaction
07.2.2 Genetics
07.2.3 Environmental factors
07.3 Prognosis
07.4 Epidemiology
07.4.1 Global
07.4.2 UK
07.4.3 US
07.5 Symptoms
07.6 Diagnosis and testing
07.7 Treatment
07.7.1 Medical treatment options
07.7.2 Surgical procedures
08.Pipeline Portfolio
08.1 Crohn’s disease pipeline landscape
08.1.1 Some emerging therapeutic options
08.2 Ulcerative colitis pipeline landscape
09.Market Landscape
09.1 Global inflammatory bowel disease market
09.2 Market size and forecast
09.3 Inflammatory bowel disease market in US
09.3.1 Market size and forecast
09.4 Inflammatory bowel disease market in EU
09.4.1 Market size and forecast
09.5 Inflammatory bowel disease market in Japan
09.5.1 Market size and forecast
09.6 Five forces analysis
10.Market Segmentation by Type of Disease
10.1 Crohn’s disease
10.2 Ulcerative colitis
11.Global Crohn’s Disease Market
11.1 Market size and forecast
11.2 Crohn’s disease market in US
11.2.1 Market size and forecast
11.3 Crohn’s disease market in Japan
11.3.1 Market size and forecast
12.Global Ulcerative Colitis Market
12.1 Market size and forecast
13.Market Segmentation by Drug Class
14.Market Segmentation by Type of Molecule
14.1 Biologics
14.2 Small molecules
15.Market Segmentation by Dosage Form
15.1 Solid
15.2 Liquid
16.Market Segmentation by Route of Administration
16.1 Oral
16.2 Parenteral
17.Geographical Segmentation
17.1 Segmentation of global inflammatory market by geography
17.2 Segmentation of global Crohn’s disease and ulcerative colitis markets by geography
17.3 Segmentation of global Crohn’s disease market by geography
17.4 Segmentation of global ulcerative colitis market by geography
18.Key Leading Countries
18.1 Key leading countries 2014
18.2 Key leading countries 2019
18.3 US
18.4 Japan
19.Buying Criteria
20.Market Growth Drivers
21.Drivers and their Impact
22.Market Challenges
23.Impact of Drivers and Challenges
24.Market Trends
25.Trends and their Impact
26.Vendor Landscape
26.1 Competitive scenario
26.1.1 Key news
26.1.2 Mergers and acquisitions
26.2 Market share analysis 2014
26.2.1 Competitive assessment of top drugs for inflammatory bowel disease
26.2.2 AbbVie
26.2.3 Janssen Pharmaceuticals
26.2.4 Merck
26.2.5 Biogen Idec
26.2.6 UCB
26.2.7 Shire
26.3 Other and future prominent vendors
27.Key Vendor Analysis
27.1 AbbVie
27.1.1 Key facts
27.1.2 Business overview
27.1.3 Product segmentation by revenue 2013
27.1.4 Product segmentation by revenue 2012 and 2013
27.1.5 Sales by geography
27.1.6 Business strategy
27.1.7 Key developments
27.1.8 SWOT analysis
27.2 Biogen Idec
27.2.1 Key facts
27.2.2 Business overview
27.2.3 Business segmentation by revenue 2013
27.2.4 Geographical segmentation by revenue 2013
27.2.5 Business strategy
27.2.6 Key developments
27.2.7 SWOT analysis
27.3 Janssen Pharmaceuticals
27.3.1 Key facts
27.3.2 Business overview
27.3.3 Recent developments
27.3.4 SWOT analysis
27.4 Merck
27.4.1 Key facts
27.4.2 Business overview
27.4.3 Business segmentation by revenue 2013
27.4.4 Business segmentation by revenue 2012 and 2013
27.4.5 Sales by geography
27.4.6 Business strategy
27.4.7 Key developments
27.4.8 SWOT analysis
27.5 Shire
27.5.1 Key facts
27.5.2 Business overview
27.5.3 Geographical segmentation by revenue 2013
27.5.4 Business strategy
27.5.5 Recent developments
27.5.6 SWOT analysis
27.6 UCB
27.6.1 Key facts
27.6.2 Business overview
27.6.3 Product segmentation by revenue 2013
27.6.4 Product segmentation by revenue 2012 and 2013
27.6.5 Geographical segmentation by revenue 2013
27.6.6 Business strategy
27.6.7 Recent developments
27.6.8 SWOT analysis
28.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market research methodology
Exhibit 2: Challenges and drivers of global inflammatory bowel disease market
Exhibit 3: Overview of Crohn’s disease
Exhibit 4: Classification of Crohn’s disease
Exhibit 5: Expected number of global Crohn’s disease cases 2015-2022
Exhibit 6: Global variation in incidence rates for Crohn’s disease in 2012 (in %)
Exhibit 7: Prevalence of Crohn’s disease in US
Exhibit 8: Incidence of Crohn’s disease in US
Exhibit 9: Symptoms of Crohn’s disease
Exhibit 10: Crohn’s disease: diagnosis and testing
Exhibit 11: Crohn’s disease: treatment
Exhibit 12: Treatment landscape for Crohn’s disease
Exhibit 13: Crohn’s disease: treatment pathway
Exhibit 14: Ulcerative colitis: Symptoms
Exhibit 15: Diagnostic approach for ulcerative colitis
Exhibit 16: Treatment options for ulcerative colitis
Exhibit 17: Surgical procedures to treat ulcerative colitis
Exhibit 18: Crohn’s disease: pipeline portfolio
Exhibit 19: Crohn’s disease clinical trial by phase
Exhibit 20: Crohn’s disease clinical trial by status
Exhibit 21: Ulcerative colitis: pipeline portfolio
Exhibit 22: Snapshot of global inflammatory bowel disease market 2014
Exhibit 23: Global inflammatory bowel disease market 2014-2019 ($ million)
Exhibit 24: Inflammatory bowel disease market in US 2014-2019 ($ million)
Exhibit 25: Inflammatory bowel disease market in EU 2014-2019 ($ million)
Exhibit 26: Inflammatory bowel disease market in Japan 2014-2019 ($ million)
Exhibit 27: Segmentation of global inflammatory bowel disease market by type of disease
Exhibit 28: Segmentation of global inflammatory bowel disease market by type of disease 2014
Exhibit 29: Segmentation of global inflammatory bowel disease market by type of disease 2019
Exhibit 30: Revenue of global inflammatory bowel disease market 2014-2019 ($ million)
Exhibit 31: Snapshot of global Crohn’s disease market 2014
Exhibit 32: Global Crohn’s disease market 2014-2019 ($ million)
Exhibit 33: Crohn’s disease market in US 2014-2019 ($ million)
Exhibit 34: Crohn’s disease market in Japan 2014-2019 ($ million)
Exhibit 35: Snapshot of global ulcerative colitis market
Exhibit 36: Global ulcerative colitis market 2014-2019 ($ million)
Exhibit 37: Segmentation of global inflammatory bowel disease market by drug class
Exhibit 38: Benefits and risks of 5-ASA
Exhibit 39: Segmentation of global inflammatory bowel disease market by drug class 2014
Exhibit 40: Segmentation of global inflammatory bowel disease market by type of molecule
Exhibit 41: Segmentation of global inflammatory bowel disease market by type of molecule 2014
Exhibit 42: Segmentation of global inflammatory bowel disease market by dosage form
Exhibit 43: Segmentation of global inflammatory bowel disease market by dosage form 2014
Exhibit 44: Segmentation of global inflammatory bowel disease market by route of administration
Exhibit 45: Segmentation of global inflammatory bowel disease market by route of administration 2014
Exhibit 46: Segmentation of global inflammatory bowel disease market by geography 2014
Exhibit 47: Segmentation of global inflammatory bowel disease market by geography 2019
Exhibit 48: Segmentation of global Crohn’s disease market by geography 2014
Exhibit 49: Segmentation of global ulcerative colitis market by geography 2014
Exhibit 50: Major drivers of global inflammatory bowel disease market
Exhibit 51: Major challenges in global inflammatory bowel disease market
Exhibit 52: Major trends in global inflammatory bowel disease market
Exhibit 53: Ranking of vendors 2014
Exhibit 54: YoY revenue of top drugs for inflammatory bowel disease 2010-2014 ($ million)
Exhibit 55: Revenue share of top drugs for inflammatory bowel disease 2010-2014
Exhibit 56: AbbVie: product portfolio
Exhibit 57: YoY global revenue of Humira 2009-2014 ($ million)
Exhibit 58: YoY revenue of Humira in US 2009-2014 ($ million)
Exhibit 59: YoY international revenue of Humira (except US) 2009-2014 ($ million)
Exhibit 60: Revenue comparison of Humira 2009-2014 ($ million)
Exhibit 61: Janssen: product portfolio
Exhibit 62: YoY global revenue of Remicade 2009-2014 ($ million)
Exhibit 63: YoY global revenue of Simponi 2010-2014 ($ million)
Exhibit 64: Merck: product portfolio
Exhibit 65: YoY global revenue of Remicade 2009-2014 ($ million)
Exhibit 66: YoY global revenue of Simponi 2010-2014 ($ million)
Exhibit 67: Biogen Idec: product portfolio
Exhibit 68: YoY global revenue of Tysabri 2009-2014 ($ million)
Exhibit 69: YoY revenue of Tysabri in US 2009-2014 ($ million)
Exhibit 70: YoY revenue of Tysabri in ROW 2009-2014 ($ million)
Exhibit 71: Global revenue of Tysabri 2009-2014 ($ million)
Exhibit 72: UCB: product portfolio
Exhibit 73: YoY global revenue of Cimzia 2010-2014 ($ million)
Exhibit 74: Shire: product portfolio
Exhibit 75: YoY global revenue of Lialda 2010-2014 ($ million)
Exhibit 76: AbbVie: product segmentation by revenue 2013
Exhibit 77: AbbVie: product segmentation by revenue 2012 and 2013 ($ million)
Exhibit 78: AbbVie: sales by geography 2013
Exhibit 79: Biogen Idec: business segmentation by revenue 2013
Exhibit 80: Biogen Idec: geographical segmentation by revenue 2013
Exhibit 81: Merck: business segmentation by revenue 2013
Exhibit 82: Merck: business segmentation by revenue 2012 and 2013 ($ billion)
Exhibit 83: Merck: sales by geography 2013
Exhibit 84: Shire: geographical segmentation by revenue 2013
Exhibit 85: UCB: product segmentation by revenue 2013
Exhibit 86: UCB: product segmentation by revenue 2012 and 2013 ($ million)
Exhibit 87: UCB: geographical segmentation by revenue 2013
【レポート販売概要】
■ タイトル：炎症性腸疾患（IBD）治療薬の世界市場：クローン病、潰瘍性大腸炎■ 英文：Global Inflammatory Bowel Disease Market 2015-2019
■ 発行日：2015年4月15日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5692
■ 調査対象地域：グローバル
- AFP：医療検査市場2014The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technolog …
- 世界の自動車スパークプラグ及びグロープラグ市場2015The Global Automotive Spark & Glow Plugs Industry Report 2015 is a professional and in-depth study on the current state of the Automotive Spark & Glow Plugs industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Spark & Glow Plugs market analysis is provided for the international markets includ …
- 固定衛星業務（FSS）の世界市場2016-2020About FSS An FSS is a type of service that uses geosynchronous satellites to broadcast through TV and radio, telecommunications, and satellite communication that are used by governments, military organizations, small and large enterprises, and other end-users. It can provide information to intelligence and security organizations. FSS is classified into wholesale services and managed services. The …
- 酸化鉄ナノ粒子の世界市場2010-2025Iron oxide nanoparticles (FeO-NPs) have attracted extensive interest due to their super paramagnetic properties and their potential applications in many fields, especially biomedicine. Applications include: • Groundwater & wastewater cleanup. • Pigments in automotive and cosmetics. • Polishing media. • Colour imaging. • Electromagnetic-wave absorption. • Magnetic detectors. • Electromagnetorheolog …
- サージ保護デバイス（SPD）の世界市場予測（～2022）The surge protection devices market is expected to grow from an estimated USD 2.06 Billion in 2017 to USD 2.68 Billion by 2022, registering a CAGR of 5.47%, from 2017 to 2022. The global market is set to witness significant growth due to growing demand for protection systems for electronic devices, power quality issues, a rise in alternative energy programs, and cost escalation due to frequent equ …
- Concho Resources Inc.社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Concho Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Concho Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- ニッケルの世界市場動向2014/2015The report presents a thorough study of nickel, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing nickel worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: nickel production in the country, major manufacturers …
- チルドビーム装置の世界市場：アクティブチルドビーム、パッシブチルドビーム、マルチサービスチルドビームChilled beam systems comprise air conditioning and ventilation systems that are capable of providing energy-efficient thermal comfortto occupants in several building applications such as commercial offices, hotels, healthcare facilities, educational institutions, and others.It also helps users increase theirreturn on investment (ROI) and reduces the costs significantly by saving energy up to 40% o …
- 防火ガラスの世界市場分析：製品別（ワイヤー入り、セラミック、強化、ゲル充填）、用途別（建設、海洋）、セグメント予測The global fire resistant glass market is expected to reach USD 7.28 billion by 2024, according to a new report by Grand View Research, Inc. Rising demand for fire resistant glass owing to the increasing investments by the regional governments on infrastructure development in emerging regions including Asia Pacific and the Middle East is expected to drive the market over the next eight years. Risi …
- 世界の商用ヘリコプタ市場動向2013-2023：トレンド、開発動向及び課題Technological Developments in the global Commercial Helicopter include: ■ Manufacturers making efforts to achieve new speed records through technological innovations ■ Green Technology ■ Improved features in Avionics by Garmin for Helicopter Operations
- 油田刺激用化学薬品の世界市場：ゲル化剤、界面活性剤、摩擦低減剤、腐食防止剤、スケール防止剤Well stimulation is generally carried out to increase the productivity of the wells by enhancing the flow of hydrocarbons over and above the projected rate of flow in both green and brown wells. Well stimulation process can be carried out at any time over the lifespan of the well. Generally, well stimulation processes are carried out at the time of well completion in almost all new wells in order …
- アルミニウム押出製品の世界市場：圧延仕上げアルミニウム、アルマイト、パウダーコーティングアルミニウムAbout the Aluminum Extrusion Market Aluminum extrusion is a method in which aluminum alloy billets are heated to 800-925 °F and subject to the extrusion process. Extruded aluminum includes mill finished, anodized, and powder-coated aluminum. Aluminum extrusions are used in many sectors, such as the construction, transportation, electrical, machinery, and consumer durables, due to their high streng …
- 医薬品倉庫の世界市場2017-2021About Pharmaceutical WarehousingPharmaceutical warehousing involves physical movement of medicinal stock in and out of a medical store warehouse. It ensures the constant flow and availability of essential quality health commodities in a timely and cost-efficient manner, and in appropriate quantities through the supply chain system. Technavio’s analysts forecast the global pharmaceutical warehousin …
- 射撃検知システムの世界市場予測（～2022年）The gunshot detection system market is projected to grow from USD 726.3 Million in 2016 to USD 3,099.8 Million by 2022, at a CAGR of 27.36% during the forecast period. Factors such as lack of stringent gun-ownership laws and easy availability of guns have resulted in an increase in gun deaths in the U.S. The use of gunshot detection systems in the military has increased due to the rise of terroris …
- 美容用レーザーの世界市場分析：用途別（IPLレーザー治療、レーザー皮膚表面修復、非侵襲的引き締め、レーザー補助下脂肪形成術、レーザー脱毛）、セグメント予測 2024The global aesthetic lasers market is expected to reach USD 1.8 billion by 2024, according to a new report by Grand View Research, Inc. The demand is expected to upsurge due to aging population, high prevalence of obesity, and wide range of safe and effective treatments. Moreover, growing awareness about the safety and efficacy of lasers coupled with its ease of use is also expected to propel its …
